Bortezomib in Treating Children With Advanced Solid Tumors

NCT00021216 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Cancer Institute (NCI)